Drug Shortage Report for ALOMIDE

Last updated on 2018-06-19 History
Report ID 51063
Drug Identification Number 00893560
Brand name ALOMIDE
Common or Proper name ALOMIDE SOLN 10ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) LODOXAMIDE
Strength(s) 0.1%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 10ML
ATC code S01GX
ATC description DECONGESTANTS AND ANTIALLERGICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-30
Estimated end date 2018-06-13
Actual end date 2018-06-13
Shortage status Resolved
Updated date 2018-06-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-06-19 French Compare
v4 2018-06-19 English Compare
v3 2018-06-01 French Compare
v2 2018-06-01 English Compare
v1 2018-06-01 English Compare

Showing 1 to 5 of 5